These findings reveal a novel, transactivation-independent mechanism of p53-mediated repression, expanding our understanding of p53’s tumor-suppressive functions and suggesting DREAM complex targeting as potential future avenues in cancer therapy. This evidence concerns the gene KCNIP3 and neoplasm.